APHERESIS EQUIPMENT MARKET ANALYSIS

Apheresis Equipment Market, By Equipment Type (Disposable Apheresis Kits and Apheresis Machines), By Technology Type (Centrifugation and Membrane Filtration), By Procedure Type (Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Others (Lymphopheresis, lipidpheresis)), By Application (Renal disorders, Neurological disorders, Hematological disorders, and Other disorders), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Blood Donation Centers, and Others)

Global Apheresis Equipment Market - Recent Developments

Key Developments

On May 25, 2023, Terumo Corporation a medical device company launched the first training program of its kind to help cell and gene therapy manufacturers improve their cell collection processes and accelerate the commercialization of therapeutics. This new program trains the participants in apheresis.
In January 2020, Fresenius Kabi AG a pharmaceutical company inaugurated the US$ 32.2 Mn (€30 Mn) expansion of transfusion and apheresis disposables plant in Dominican Republic. This plant expansion will strengthen the company’s role as a major global exporter of apheresis and plasma collection sets.

Collaborations

In June 2022, Terumo Corporation a medical device company collaborated with GenCure, a pharmaceutical company to extend and unify cell and gene therapy manufacturing solutions. This collaboration enhances transition between clinical and manufacturing sites by enabling chain-of-custody/identity and consistency of leukapheresis products.
In July 2022, TERUMO BCT, INC. a cell technology company collaborated with Eliaz Therapeutics a medical device company for the development and commercialization of a Novel Therapeutic Apheresis Treatment for Acute Kidney Injury (AKI)